Marty Nazzaro
Direttore operativo presso Inflammasome Therapeutics, Inc.
Profilo
Marty Nazzaro is currently the Vice President-Operations at Inflammasome Therapeutics, Inc. He previously worked as a Manufacturing Director at Control Delivery Systems, Inc. and as an Operations Director at EyePoint Pharmaceuticals, Inc. from 2006 to 2009.
He obtained his undergraduate degree from Suffolk University.
Posizioni attive di Marty Nazzaro
| Società | Posizione | Inizio |
|---|---|---|
Inflammasome Therapeutics, Inc.
 Inflammasome Therapeutics, Inc. BiotechnologyHealth Technology Inflammasome Therapeutics, Inc. develops therapies for prevalent and degenerative diseases. The American company was founded in 2016 by Jayakrishna Ambati and Paul Ashton. Paul Ashton has been the CEO since 2016. | Direttore operativo | 01/03/2020 |
Precedenti posizioni note di Marty Nazzaro
| Società | Posizione | Fine |
|---|---|---|
Control Delivery Systems, Inc.
 Control Delivery Systems, Inc. Medical SpecialtiesHealth Technology Control Delivery Systems Inc. designs, develops and manufactures drug delivery products. The products are designed to deliver precise quantities of drugs to difficult-to-treat areas of the body. The company was founded in 1991 and is headquartered in Watertown, MA. | Corporate Officer/Principal | - |
| EYEPOINT PHARMACEUTICALS, INC. | Direttore operativo | - |
Formazione di Marty Nazzaro
| Suffolk University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| EYEPOINT PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Control Delivery Systems, Inc.
Control Delivery Systems, Inc. Medical SpecialtiesHealth Technology Control Delivery Systems Inc. designs, develops and manufactures drug delivery products. The products are designed to deliver precise quantities of drugs to difficult-to-treat areas of the body. The company was founded in 1991 and is headquartered in Watertown, MA. | Health Technology |
Inflammasome Therapeutics, Inc.
Inflammasome Therapeutics, Inc. BiotechnologyHealth Technology Inflammasome Therapeutics, Inc. develops therapies for prevalent and degenerative diseases. The American company was founded in 2016 by Jayakrishna Ambati and Paul Ashton. Paul Ashton has been the CEO since 2016. | Health Technology |
- Borsa valori
- Insiders
- Marty Nazzaro
